IPIC:
Had an up-gap this morning on the news that they have a product that could make condoms obsolete for HIV protection <g>
Today's volume of 2,893,800 was larger than Jan.30's volume of 1,651,900 Although today's intra-day H of 4.12 was higher than Jan.30's 4.09 the closing today at 3.84 was lower than Jan.30's at 4.06
Will see tomorrow if today was just a temporary "double top" and if it can go to test the March's H at 5.81
If they still have not presented the "study at the Chicago conference that started Sunday and runs until Thursday the test of the March H is the most likely possibility. In the second week of February last year it went from a low of 2.12 to a H of 7.56 Of course those times were different <g>
Here is some of today's news:
LEXINGTON, Mass.--(BUSINESS WIRE)--Feb. 6, 2001--Researchers have demonstrated that a vaginal microbicide under development by Interneuron Pharmaceuticals, Inc. (NASDAQ: IPIC - news) can afford protection against viral infection in a rhesus monkey model of the sexual transmission of HIV (human immunodeficiency virus), the virus that causes AIDS (acquired immunodeficiency syndrome).
In a study supported by the National Institutes of Health (NIH) and conducted by the Southern Research Institute (SRI), most animals treated with the microbicide, known as PRO 2000, remained uninfected and healthy following exposure to a highly infectious dose of an HIV-like virus when compared to untreated animals. Complete findings from the study will be presented by Dr. Mark Lewis of SRI at the 8th Conference on Retroviruses and Opportunistic Infections in Chicago (February 4 - 8, 2001).
``These findings strengthen the rationale for developing PRO 2000 as a topical microbicide to prevent HIV infection,'' said Dr. Albert Profy, vice president of preclinical development at Interneuron. ``We believe this protection is conferred through prevention of HIV entry into susceptible human cells. The additional scientific evidence from the study provides further justification for expanded human testing.''
Bernard |
